Macular Degeneration News and Research RSS Feed - Macular Degeneration News and Research

Macular degeneration is a disease associated with aging that gradually destroys sharp, central vision. Central vision is needed for seeing objects clearly and for common daily tasks such as reading and driving.
Chemotherapy-induced senescent cells promote side effects and cancer relapse

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Standard chemotherapy is a blunt force instrument against cancer - and it's a rare cancer patient who escapes debilitating side effects from systemic treatments that mostly affect dividing cells, both malignant and healthy, throughout the body. [More]
VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study. [More]
New imaging technique could revolutionize assessment of eye health and disease

New imaging technique could revolutionize assessment of eye health and disease

Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed. [More]
How to stay safe in the sun

How to stay safe in the sun

When choosing a sunscreen, you must first consider what you will be doing when wearing it, for example if you're running, the sunscreen you choose must be able to withstand sweating. [More]
Researchers use worms as model system to study how gut microbiome influences disease

Researchers use worms as model system to study how gut microbiome influences disease

The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood. [More]
URMC researchers identify potential new means of treating severe genetic diseases in children

URMC researchers identify potential new means of treating severe genetic diseases in children

University of Rochester Medical Center researchers believe they have identified a potential new means of treating some of the most severe genetic diseases of childhood, according to a study in PLOS Biology. [More]
New book provides insights into latest treatments for partial blindness

New book provides insights into latest treatments for partial blindness

In Restoring Low Vision, renowned neuroscientist Bernhard Sabel explains cutting-edge science in language that patients can easily understand and provides a comprehensive look at the latest treatments for partial blindness. [More]
TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI). [More]
Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020. [More]
Noninvasive biomedical imaging technology uses light to map the brain

Noninvasive biomedical imaging technology uses light to map the brain

Scientific progress has provided a solid understanding of the anatomy of the brain. However, there is still no reliable way to examine neuron to neuron communication, as it happens--a key to understanding the correlation between brain structure and brain function. [More]
Researchers call sun avoidance as emerging health problem in the U.S.

Researchers call sun avoidance as emerging health problem in the U.S.

A landmark study published Friday in the Journal Dermato-Endocrinology has world-renowned researchers calling insufficient sun exposure an emerging health problem in the United States. [More]
Research provides new insight into possible causes of AMD among older people

Research provides new insight into possible causes of AMD among older people

Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older. [More]
Education has greater influence on development of myopia than cognitive ability, study finds

Education has greater influence on development of myopia than cognitive ability, study finds

Environmental factors such as education and leisure activities have a greater influence on the development of short-sightedness or myopia than the ability to think logically and solve problems. [More]
Gut microbiota may play important role in influencing onset of blinding wet AMD

Gut microbiota may play important role in influencing onset of blinding wet AMD

Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the industrialized world, affecting over 10 million individuals in North America. [More]
Discovery of novel protein could lead to potential new treatments for age-related retinal disease

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life. [More]
TSRI study suggests new approach to limit tumor growth by targeting immune system cells

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

A new study led by scientists at The Scripps Research Institute suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages. [More]
Ophthalmologists focus on dim-light driving situations that can endanger drivers and pedestrians

Ophthalmologists focus on dim-light driving situations that can endanger drivers and pedestrians

As the end of daylight saving time draws near, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue — dim-light driving situations that can endanger drivers and pedestrians. [More]
Researchers map two gene mutations that trigger retinal disease leading to macular degeneration

Researchers map two gene mutations that trigger retinal disease leading to macular degeneration

Two gene mutations that trigger a retinal disease that causes blindness in one in 5,000 males have been mapped, leading to the potential for new therapeutic treatments. [More]
Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I). [More]
Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

The long-term safety of gene transfer to treat neovascular age-related macular degeneration (NVAMD), and the production of two therapeutic proteins encoded by those genes for at least 2.5 years in the eyes of patients with advanced NVAMD are demonstrated in the results of a clinical trial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Advertisement
Advertisement